HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5675-5686

  Matthews, Philippa C ^a   Adland, Emily ^a   Listgarten, Jennifer ^b   Leslie, Alasdair ^c   Mkhwanazi, Nompumelelo ^d   Carlson, Jonathan M ^b   Harndahl, Mikkel ^e   Stryhn, Anette ^e   Payne, Rebecca P ^a   Ogwu, Anthony ^f   Huang, Kuan Hsiang Gary ^g   Frater, John ^g   Paioni, Paolo ^a   Kloverpris, Henrik ^a   Jooste, Pieter ^h   Goedhals, Dominique ^h   Van Vuuren, Cloete ^h   Steyn, Dewald ^h   Riddell, Lynn ⁱ   Chen, Fabian ^j   Luzzi, Graz ^k   Balachandran, Thambiah ^l   Ndung'u, Thumbi ^d   Buus, Søren ^e   Carrington, Mary ^m,n   Shapiro, Roger ^f,o   Heckerman, David ^b   Goulder, Philip J R ^a,d   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MICROSOFT RESEARCH   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY OF THE FREE STATE   (South Africa)

ⁱ NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^j ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^k WYCOMBE HOSPITAL   (United Kingdom)

^l LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

^m NATIONAL CANCER INSTITUTE   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^o HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; NEF PROTEIN; POL PROTEIN; REV PROTEIN; HLA B*5703 ANTIGEN; HLA-B*5703 ANTIGEN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS-1;

ADULT; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CLADISTICS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREGULATION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SOUTH AFRICA; UNINDEXED SEQUENCE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; AFRICA; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; FLOW CYTOMETRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOLECULAR GENETICS; SEQUENCE ANALYSIS; VIROLOGY;

AFRICA; ALLELES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; SEQUENCE ANALYSIS, PROTEIN; VIRAL LOAD; VIREMIA;

EID: 79956209349     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003711     Document Type: Article

References (57)

1. Brumme, Z. L., I. Tao, S. Szeto, C. J. Brumme, J. M. Carlson, D. Chan, C. Kadie, N. Frahm, C. Brander, B. Walker, et al. 2008. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 22: 1277-1286.
2. Goulder, P. J., and D. I. Watkins. 2008. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8: 619-630.
3. Matthews, P. C., A. Prendergast, A. Leslie, H. Crawford, R. Payne, C. Rousseau, M. Rolland, I. Honeyborne, J. Carlson, C. Kadie, et al. 2008. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 82: 8548-8559.
4. O'Brien, S. J., X. Gao, and M. Carrington. 2001. HLA and AIDS: a cautionary tale. Trends Mol. Med. 7: 379-381.
5. Rousseau, C. M., M. G. Daniels, J. M. Carlson, C. Kadie, H. Crawford, A. Prendergast, P. Matthews, R. Payne, M. Rolland, D. N. Raugi, et al. 2008. HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load. J. Virol. 82: 6434-6446.
6. Crawford, H., J. G. Prado, A. Leslie, S. Hué, I. Honeyborne, S. Reddy, M. van der Stok, Z. Mncube, C. Brander, C. Rousseau, et al. 2007. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81: 8346-8351. (Pubitemid 47101520)
7. Geldmacher, C., J. R. Currier, E. Herrmann, A. Haule, E. Kuta, F. McCutchan, L. Njovu, S. Geis, O. Hoffmann, L. Maboko, et al. 2007. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J. Virol. 81: 2440-2448.
8. Goulder, P. J., M. Bunce, P. Krausa, K. McIntyre, S. Crowley, B. Morgan, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1996. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses 12: 1691-1698.
9. Honeyborne, I., A. Prendergast, F. Pereyra, A. Leslie, H. Crawford, R. Payne, S. Reddy, K. Bishop, E. Moodley, K. Nair, et al. 2007. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J. Virol. 81: 3667-3672. (Pubitemid 46456679)
10. Kawashima, Y., K. Pfafferott, J. Frater, P. Matthews, R. Payne, M. Addo, H. Gatanaga, M. Fujiwara, A. Hachiya, H. Koizumi, et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
11. Leslie, A., D. A. Price, P. Mkhize, K. Bishop, A. Rathod, C. Day, H. Crawford, I. Honeyborne, T. E. Asher, G. Luzzi, et al. 2006. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. [Published erratum appears in 2006 J. Immunol. 177: 8878.] J. Immunol. 177: 4699-4708. (Pubitemid 44469803)
12. Payne, R. P., H. Kløverpris, J. B. Sacha, Z. Brumme, C. Brumme, S. Buus, S. Sims, S. Hickling, L. Riddell, F. Chen, et al. 2010. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. J. Virol. 84: 10543-10557.
13. Kiepiela, P., A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale, S. Chetty, P. Rathnavalu, C. Moore, K. J. Pfafferott, L. Hilton, et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
14. Altfeld, M., M. M. Addo, E. S. Rosenberg, F. M. Hecht, P. K. Lee, M. Vogel, X. G. Yu, R. Draenert, M. N. Johnston, D. Strick, et al. 2003. Influence of HLAB57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17: 2581-2591. (Pubitemid 38402336)
15. Crawford, H., W. Lumm, A. Leslie, M. Schaefer, D. Boeras, J. G. Prado, J. Tang, P. Farmer, T. Ndung'u, S. Lakhi, et al. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. 206: 909-921.
16. Leslie, A. J., K. J. Pfafferott, P. Chetty, R. Draenert, M. M. Addo, M. Feeney, Y. Tang, E. C. Holmes, T. Allen, J. G. Prado, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10: 282-289.
17. Martinez-Picado, J., J. G. Prado, E. E. Fry, K. Pfafferott, A. Leslie, S. Chetty, C. Thobakgale, I. Honeyborne, H. Crawford, P. Matthews, et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80: 3617-3623.
18. Kawashima, Y., M. Satoh, S. Oka, T. Shirasaka, and M. Takiguchi. 2008. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS. Biochem. Biophys. Res. Commun. 366: 612-616.
19. Koehler, R. N., A. M. Walsh, E. Saathoff, S. Tovanabutra, M. A. Arroyo, J. R. Currier, L. Maboko, M. Hoelscher, M. L. Robb, N. L. Michael, et al. 2010. Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania. [Published erratum appears in 2011 J. Infect. Dis. 203: 749.] J. Infect. Dis. 202: 1562-1566.
20. Schaubert, K. L., D. A. Price, N. Frahm, J. Li, H. L. Ng, A. Joseph, E. Paul, B. Majumder, V. Ayyavoo, E. Gostick, et al. 2007. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope. J. Immunol. 178: 7756-7766. (Pubitemid 46898047)
21. Tang, J., W. Shao, Y. J. Yoo, I. Brill, J. Mulenga, S. Allen, E. Hunter, and R. A. Kaslow. 2008. Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples. J. Immunol. 181: 2626-2635.
22. Fellay, J., K. V. Shianna, D. Ge, S. Colombo, B. Ledergerber, M. Weale, K. Zhang, C. Gumbs, A. Castagna, A. Cossarizza, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947. (Pubitemid 47301321)
23. Leslie, A., P. C. Matthews, J. Listgarten, J. M. Carlson, C. Kadie, T. Ndung'u, C. Brander, H. Coovadia, B. D. Walker, D. Heckerman, and P. J. Goulder. 2010. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J. Virol. 84: 9879-9888.
24. Semeniuk, C. A., L. McKinnon, H. O. Peters, M. Gubbins, X. Mao, T. B. Ball, M. Luo, and F. A. Plummer. 2009. Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag. AIDS 23: 771-777.
25. Catano, G., H. Kulkarni, W. He, V. C. Marconi, B. K. Agan, M. Landrum, S. Anderson, J. Delmar, V. Telles, L. Song, et al. 2008. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 3: e3636.
26. Naugler, C. 2010. Origins and relatedness of human leukocyte antigen class I allele supertypes. Hum. Immunol. 71: 837-842.
27. Sidney, J., B. Peters, N. Frahm, C. Brander, and A. Sette. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9: 1-15.
28. Middleton, D., L. Menchaca, H. Rood, and R. Komerofsky. 2003. New allele frequency database. Tissue Antigens 64: 403-407.
29. Kiepiela, P., K. Ngumbela, C. Thobakgale, D. Ramduth, I. Honeyborne, E. Moodley, S. Reddy, C. de Pierres, Z. Mncube, N. Mkhwanazi, et al. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13: 46-53.
30. Huang, K. H., D. Goedhals, H. Fryer, C. van Vuuren, A. Katzourakis, T. De Oliveira, H. Brown, S. Cassol, C. Seebregts, A. McLean, et al; Bloemfontein- Oxford Collaborative Group. 2009. Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa. Antivir. Ther. (Lond.) 14: 975-984.
31. Leslie, A., D. Kavanagh, I. Honeyborne, K. Pfafferott, C. Edwards, T. Pillay, L. Hilton, C. Thobakgale, D. Ramduth, R. Draenert, et al. 2005. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 201: 891-902.
32. Frater, A. J., H. Brown, A. Oxenius, H. F. Günthard, B. Hirschel, N. Robinson, A. J. Leslie, R. Payne, H. Crawford, A. Prendergast, et al. 2007. Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J. Virol. 81: 6742-6751. (Pubitemid 46878078)
33. Honeyborne, I., A. Rathod, R. Buchli, D. Ramduth, E. Moodley, P. Rathnavalu, S. Chetty, C. Day, C. Brander, W. Hildebrand, et al. 2006. Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa. J. Immunol. 176: 4699-4705.
34. Parham, P. 1992. Immunology. Deconstructing the MHC. Nature 360: 300-301.
35. Harndahl, M., S. Justesen, K. Lamberth, G. Røder, M. Nielsen, and S. Buus. 2009. Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays. J. Biomol. Screen. 14: 173-180.
36. Lancaster, A. K., R. M. Single, O. D. Solberg, M. P. Nelson, and G. Thomson. 2007. PyPop update - a software pipeline for large-scale multilocus population genomics. Tissue Antigens 69(Suppl. 1): 192-197. (Pubitemid 46625883)
37. Marsh, S. G. E., P. Parham, and L. D. Barber. 2000. The HLA Facts Book. Academic Press, London.
38. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50: 201-212. (Pubitemid 30099525)
39. Oxenius, A., B. K. Jakobsen, P. J. Easterbrook, J. M. Boulter, T. Tun, A. Waters, J. Agudelo, M. Barnardo, R. E. Phillips, and D. A. Price. 2002. Complete mapping of a novel HLA A*6801-restricted HIV-1 Tat epitope directly with a rapid modified enzyme-linked immunospot assay. AIDS 16: 1285-1287.
40. Bhattacharya, T., M. Daniels, D. Heckerman, B. Foley, N. Frahm, C. Kadie, J. Carlson, K. Yusim, B. McMahon, B. Gaschen, et al. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315: 1583-1586. (Pubitemid 46449476)
41. Kaul, R., T. Dong, F. A. Plummer, J. Kimani, T. Rostron, P. Kiama, E. Njagi, E. Irungu, B. Farah, J. Oyugi, et al. 2001. CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J. Clin. Invest. 107: 1303-1310.
42. Cozzi Lepri, A., T. L. Katzenstein, H. Ullum, A. N. Phillips, P. Skinhøj, J. Gerstoft, and B. K. Pedersen. 1998. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection. AIDS 12: 1639-1643.
43. Sacha, J. B., C. Chung, E. G. Rakasz, S. P. Spencer, A. K. Jonas, A. T. Bean, W. Lee, B. J. Burwitz, J. J. Stephany, J. T. Loffredo, et al. 2007. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 178: 2746-2754. (Pubitemid 46333151)
44. Chopera, D. R., Z. Woodman, K. Mlisana, M. Mlotshwa, D. P. Martin, C. Seoighe, F. Treurnicht, D. A. de Rosa, W. Hide, S. A. Karim, et al; CAPRISA 002 Study Team. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 4: e1000033.
45. Goepfert, P. A., W. Lumm, P. Farmer, P. Matthews, A. Prendergast, J. M. Carlson, C. A. Derdeyn, J. Tang, R. A. Kaslow, A. Bansal, et al. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J. Exp. Med. 205: 1009-1017.
46. Thobakgale, C. F., A. Prendergast, H. Crawford, N. Mkhwanazi, D. Ramduth, S. Reddy, C. Molina, Z. Mncube, A. Leslie, J. Prado, et al. 2009. Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. J. Virol. 83: 10234-10244.
47. Borghans, J. A., A. Mølgaard, R. J. de Boer, and C. Keşmir. 2007. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS ONE 2: e920.
48. Boutwell, C. L., C. F. Rowley, and M. Essex. 2009. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. J. Virol. 83: 2460-2468.
49. Schneidewind, A., M. A. Brockman, J. Sidney, Y. E. Wang, H. Chen, T. J. Suscovich, B. Li, R. I. Adam, R. L. Allgaier, B. R. Mothé, et al. 2008. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 82: 5594-5605. (Pubitemid 351705266)
50. Goulder, P. J., S. W. Reid, D. A. Price, C. A. O'Callaghan, A. J. McMichael, R. E. Phillips, and E. Y. Jones. 1997. Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes. Eur. J. Immunol. 27: 1515-1521.
51. Thananchai, H., G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al. 2007. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178: 33-37. (Pubitemid 46033585)
52. Streeck, H., M. Lichterfeld, G. Alter, A. Meier, N. Teigen, B. Yassine-Diab, H. K. Sidhu, S. Little, A. Kelleher, J. P. Routy, et al. 2007. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J. Virol. 81: 7725-7731. (Pubitemid 47047858)
53. Alter, G., S. Rihn, K. Walter, A. Nolting, M. Martin, E. S. Rosenberg, J. S. Miller, M. Carrington, and M. Altfeld. 2009. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 83: 6798-6805.
54. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
55. Ngumbela, K. C., C. L. Day, Z. Mncube, K. Nair, D. Ramduth, C. Thobakgale, E. Moodley, S. Reddy, C. de Pierres, N. Mkhwanazi, et al. 2008. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res. Hum. Retroviruses 24: 72-82.
56. Gray, C. M., M. Mlotshwa, C. Riou, T. Mathebula, D. de Assis Rosa, T. Mashishi, C. Seoighe, N. Ngandu, F. van Loggerenberg, L. Morris, et al; CAPRISA 002 Acute Infection Study Team. 2009. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point. J. Virol. 83: 470-478.
57. Carlson, J. M., Z. L. Brumme, C. M. Rousseau, C. J. Brumme, P. Matthews, C. Kadie, J. I. Mullins, B. D. Walker, P. R. Harrigan, P. J. Goulder, and D. Heckerman. 2008. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLOS Comput. Biol. 4: e1000225.